Qiagen N.V. Logo

Qiagen N.V.

ISIN: NL0012169213 | Ticker: QIA | LEI: 54930036WK3GMCN17Z57
Sector: Health CareSub-Industry: Health Care Services
Country: Germany

About Qiagen N.V.

Company Description

QIAGEN serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life – DNA, RNA and proteins. We deliver Sample to Insight solutions for molecular testing, propelling our customers from start to finish to unlock new insights. This is how we make improvements in life possible.

Our product portfolio supports our customers across the continuum of molecular testing in molecular diagnostics and life sciences. From the first important step of DNA, RNA and protein extraction from biological samples, to novel testing technologies targeting single or multiple molecular variants, and software to analyze and interpret molecular data to deliver valuable insights. Our automation systems bring together all of these steps in seamless end-to-end workflows.

Year founded

1984

Served area

Worldwide

Headcount

5,472

Headquarters

Qiagen Str. 1, 40724 Hilden – Germany

Financial statements

Download as Excel
Line item in (usd) 01.01.2019 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 5,264,254,000.00 5,928,287,000.00 6,208,790,000.00 6,351,748,000.00
Noncurrent Assets N/A 3,752,445,000.00 4,329,485,000.00 4,135,607,000.00 3,987,641,000.00
Property Plant And Equipment N/A 356,100,000.00 427,352,000.00 491,357,000.00 492,582,000.00
Goodwill N/A 2,166,213,000.00 2,389,111,000.00 2,376,440,000.00 2,380,162,000.00
Intangible Assets Other Than Goodwill N/A 750,599,000.00 883,600,000.00 803,192,000.00 748,648,000.00
Investment Accounted For Using Equity Method N/A 9,729,000.00 11,017,000.00 21,549,000.00 18,217,000.00
Deferred Tax Assets N/A 77,610,000.00 89,016,000.00 117,365,000.00 89,440,000.00
Other Noncurrent Financial Assets N/A 94,187,000.00 4,408,000.00 3,945,000.00 5,329,000.00
Noncurrent Derivative Financial Assets N/A 192,266,000.00 379,080,000.00 190,430,000.00 131,354,000.00
Other Noncurrent Assets N/A 49,700,000.00 44,690,000.00 31,914,000.00 27,927,000.00
Current Assets N/A 1,511,809,000.00 1,598,802,000.00 2,073,183,000.00 2,364,107,000.00
Inventories N/A 170,704,000.00 291,181,000.00 327,525,000.00 358,487,000.00
Trade And Other Current Receivables N/A 376,281,000.00 380,519,000.00 362,131,000.00 323,750,000.00
Current Tax Assets Current N/A 42,119,000.00 59,335,000.00 N/A N/A
Other Current Financial Assets N/A 107,118,000.00 117,249,000.00 184,785,000.00 687,597,000.00
Cash and cash equivalents N/A 622,486,000.00 597,003,000.00 879,884,000.00 730,271,000.00
Current Restricted Cash And Cash Equivalents N/A 5,743,000.00 0.00 N/A N/A
Current Derivative Financial Assets N/A 107,868,000.00 14,127,000.00 175,284,000.00 111,617,000.00
Other Current Assets N/A 79,490,000.00 198,723,000.00 143,574,000.00 152,385,000.00
Equity And Liabilities N/A 5,264,254,000.00 5,928,287,000.00 6,208,790,000.00 6,351,748,000.00
Equity 2,378,815,000.00 2,323,847,000.00 2,483,049,000.00 2,858,892,000.00 3,389,293,000.00
Issued Capital N/A 2,702,000.00 2,702,000.00 2,702,000.00 2,702,000.00
Retained Earnings N/A 948,186,000.00 998,133,000.00 1,490,974,000.00 1,981,498,000.00
Share Premium N/A 1,790,504,000.00 1,840,115,000.00 1,877,704,000.00 1,921,972,000.00
Treasury Shares N/A 111,966,000.00 118,301,000.00 189,730,000.00 160,188,000.00
Other Reserves N/A -305,579,000.00 -239,600,000.00 -322,758,000.00 -356,691,000.00
Noncurrent Liabilities N/A 1,988,913,000.00 2,874,343,000.00 1,724,053,000.00 1,938,163,000.00
Deferred Tax Liabilities N/A 28,486,000.00 46,041,000.00 45,238,000.00 26,116,000.00
Noncurrent Derivative Financial Liabilities N/A 435,592,000.00 766,410,000.00 429,402,000.00 293,725,000.00
Other Noncurrent Liabilities N/A 106,201,000.00 186,724,000.00 209,320,000.00 200,475,000.00
Longterm Borrowings N/A 1,418,634,000.00 1,875,168,000.00 1,040,093,000.00 1,417,847,000.00
Current Liabilities N/A 951,494,000.00 570,895,000.00 1,625,845,000.00 1,024,292,000.00
Current Provisions N/A 8,129,000.00 6,565,000.00 6,715,000.00 5,967,000.00
Trade And Other Current Payables N/A 84,767,000.00 118,153,000.00 101,224,000.00 98,734,000.00
Current Tax Liabilities Current N/A 34,082,000.00 57,676,000.00 N/A N/A
Current Derivative Financial Liabilities N/A 103,175,000.00 51,464,000.00 292,204,000.00 161,021,000.00
Other Current Liabilities N/A 436,097,000.00 352,174,000.00 380,047,000.00 369,018,000.00
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A 285,244,000.00 42,539,000.00 845,655,000.00 389,552,000.00
Line item in (usd) 01.01.2019/
01.01.2020
01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 1,526,424,000.00 1,870,346,000.00 2,251,657,000.00 2,143,020,000.00
Other Income 4,126,000.00 992,000.00 572,000.00 282,000.00
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 154,828,000.00 1,034,000.00 0.00 N/A
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 154,828,000.00 1,034,000.00 0.00 N/A
Profit Loss From Operating Activities -50,452,000.00 383,916,000.00 635,681,000.00 533,323,000.00
Gains Losses On Net Monetary Position N/A N/A 0.00 -5,393,000.00
Finance Income 22,113,000.00 10,032,000.00 9,555,000.00 33,241,000.00
Finance Costs 75,756,000.00 73,002,000.00 56,487,000.00 60,090,000.00
Profit Loss Before Tax -116,721,000.00 154,927,000.00 651,102,000.00 666,646,000.00
Income Tax Expense Continuing Operations -46,951,000.00 81,287,000.00 114,048,000.00 90,985,000.00
Profit (loss) -69,770,000.00 73,640,000.00 537,054,000.00 575,661,000.00
Line item in (usd) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) -69,770,000.00 73,640,000.00 537,054,000.00 575,661,000.00
Adjustments For Decrease Increase In Inventories -30,028,000.00 -107,573,000.00 -81,803,000.00 -55,464,000.00
Adjustments For Increase Decrease In Trade Account Payable 9,252,000.00 8,442,000.00 -5,975,000.00 -1,756,000.00
Adjustments For Depreciation And Amortisation Expense 239,361,000.00 209,971,000.00 219,463,000.00 211,931,000.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 159,627,000.00 1,432,000.00 0.00 12,970,000.00
Adjustments For Sharebased Payments 65,893,000.00 40,936,000.00 38,391,000.00 49,507,000.00
Interest Paid Classified As Operating Activities 31,311,000.00 27,056,000.00 23,617,000.00 24,961,000.00
Interest Received Classified As Operating Activities 22,710,000.00 9,818,000.00 8,954,000.00 20,128,000.00
Income Taxes Paid Refund Classified As Operating Activities 41,474,000.00 42,572,000.00 102,083,000.00 98,565,000.00
Cash Flows From Used In Operating Activities 367,028,000.00 492,272,000.00 675,992,000.00 751,121,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities 68,058,000.00 239,572,000.00 0.00 63,651,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities 60,581,000.00 79,908,000.00 138,614,000.00 56,338,000.00
Purchase Of Intangible Assets Classified As Investing Activities 214,303,000.00 224,329,000.00 67,920,000.00 92,998,000.00
Other Inflows Outflows Of Cash Classified As Investing Activities -328,000.00 -3,146,000.00 -57,000.00 107,000.00
Cash Flows From Used In Investing Activities -236,958,000.00 -453,290,000.00 -211,701,000.00 -735,584,000.00
Proceeds From Issuing Shares 2,075,000.00 7,662,000.00 7,919,000.00 121,000.00
Payments To Acquire Or Redeem Entitys Shares 74,450,000.00 63,995,000.00 99,987,000.00 0.00
Payments Of Lease Liabilities Classified As Financing Activities 22,666,000.00 24,193,000.00 27,429,000.00 26,842,000.00
Other Inflows Outflows Of Cash Classified As Financing Activities -11,281,000.00 -9,610,000.00 -1,979,000.00 0.00
Cash Flows From Used In Financing Activities -661,746,000.00 -74,320,000.00 -177,795,000.00 -152,645,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents 826,000.00 4,112,000.00 -3,615,000.00 -12,505,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes -530,850,000.00 -31,226,000.00 282,881,000.00 -149,613,000.00
Cash and cash equivalents 622,486,000.00 597,003,000.00 879,884,000.00 730,271,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
ENG
ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
17.04.23 S. Rusckowski Non-Executive member Other EUR 0.00
14.03.23 E.R. Mardis Non-Executive member Sell USD 218,422.41
28.02.23 E. Pisa Non-Executive member Other USD 0.00
21.02.23 R. Sackers Non-Executive member Other USD 0.00
01.12.22 R. Sackers Non-Executive member Sell USD 1,500,000.00
31.10.22 M. Colpan Non-Executive member Other USD 0.00
08.06.22 R. Sackers Non-Executive member Sell USD 1,522,706.00
31.03.22 R. Sackers Non-Executive member Other USD 0.00
15.03.22 R. Sackers Non-Executive member Other USD 0.00
14.03.22 E.R. Mardis Non-Executive member Sell USD 228,330.77

Capital markets information

ISIN

NL0012169213

LEI

54930036WK3GMCN17Z57

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Services

Listed Stock Exchange

Frankfurt Stock Exchange

Stock Index

DAX

TecDAX

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.